Cervical cancer - cervical screening (review)
Guidance on the use of liquid-based cytology for cervical screening (TA69)
Chapter :
1. Guidance
NOTE: This guidance replaces Technology Appraisal Guidance No. 5 issued in June 2000.
The Institute reviews each piece of guidance it issues.
The review and re-appraisal of the use of liquid-based cytology for cervical screening has resulted in a change in the guidance. Specifically there has been:
- a recommendation of the use of liquid-based cytology as the primary means of processing samples in the cervical screening programme in England and Wales.
1.1. It is recommended that liquid-based cytology (LBC) is used as the primary means of processing samples in the cervical screening programme in England and Wales.
1.2. There is currently insufficient evidence to recommend one LBC product over another. The NHS Cervical Screening Programme and Cervical Screening Wales may wish to consider evaluating further the different products as the method is introduced.
